What is the price target for UNCY stock?
14 analysts have analysed UNCY and the average price target is 47.43 USD. This implies a price increase of 615.38% is expected in the next year compared to the current price of 6.63.
UNICYCIVE THERAPEUTICS INC (UNCY) Forecast, Price Target & Analyst Ratings
NASDAQ:UNCY • US90466Y2028
Current stock price
6.63 USD
-0.02 (-0.3%)
At close:
6.58 USD
-0.05 (-0.75%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for UNICYCIVE THERAPEUTICS INC (UNCY).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Mar 26, 2026
- Period
- Q4 / 2025
- EPS Estimate
- -$0.48
- Revenue Estimate
Price Target Details & History
Consensus Price Target and Range
Mean target
$47.43
Upside
+ 615.38%
From current price of $6.63 to mean target of $47.43, Based on 14 analyst forecasts
Low
$21.21
Median
$43.86
High
$94.50
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
14 Wall Street analysts provided a forecast for the next 12 months for UNCY. The average price target is 47.43 USD. This implies a price increase of 615.38% is expected in the next year compared to the current price of 6.63.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.86%
UNCY was analyzed by 14 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about UNCY.
In the previous month the buy percentage consensus was at a similar level.
UNCY was analyzed by 14 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-10-29 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-09-15 | Benchmark | Maintains | Speculative Buy -> Speculative Buy |
| 2025-04-21 | Guggenheim | Initiate | Buy |
| 2025-04-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-01 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-01-29 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-08 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-11-22 | Benchmark | Reiterate | Speculative Buy -> Speculative Buy |
| 2024-11-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-11-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-06 | Benchmark | Reiterate | Speculative Buy -> Speculative Buy |
| 2024-09-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-15 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-07-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-03 | Benchmark | Reiterate | Speculative Buy -> Speculative Buy |
| 2024-05-31 | Benchmark | Reiterate | Speculative Buy -> Speculative Buy |
| 2024-05-29 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-15 | Benchmark | Reiterate | Speculative Buy -> Speculative Buy |
| 2024-04-04 | Piper Sandler | Initiate | Overweight |
| 2024-04-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Mar 26, 2026
- Period
- Q4 / 2025
- EPS Estimate
- -$0.48
- Revenue Estimate
- Revenue Q2Q
- N/A
- EPS Q2Q
- 81.43%
- Number of Analysts
- 10
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%
Next Earnings Summary
UNCY is expected to report earnings on 3/26/2026. The consensus EPS estimate for the next earnings is -0.48 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates 2025 - 2033
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 950K | 675K -28.95% | -100.00% | 88.743M | 445.28M 401.76% | 477M 7.12% | 518.78M 8.76% | 570.98M 10.06% | 565.87M -0.89% | 361.82M -36.06% | 234.71M -35.13% | |||
| EBITDA YoY % growth | -8.98M | -18.04M -100.89% | -20.765M -15.11% | N/A -54.56% | -42.432M -32.21% | 125.77M 396.40% | 577.42M 359.11% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -8.98M -344.55% | -18.05M -101.00% | -20.774M -15.09% | -30.664M -54.60% | -29.939M 6.78% | 40.092M 233.91% | 470.32M 1,073.10% | 262.03M -44.29% | 291.4M 11.21% | 348.66M 19.65% | 318.25M -8.72% | 368.03M 15.64% | 328.77M -10.67% | |
| Operating Margin | N/A | -1,900.00% | -3,077.63% | N/A | N/A | 45.18% | 105.62% | 54.93% | 56.17% | 61.06% | 56.24% | 101.72% | 140.07% | |
| EPS YoY % growth | N/A | -12.00 -58.27% | -16.10 -34.17% | -5.14 33.54% | -1.84 82.78% | -1.35 26.80% | 15.47 1,246.82% | 6.67 -56.88% | 6.48 -2.79% | 7.70 18.72% | 8.68 12.75% | 8.97 3.35% | 8.39 -6.42% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.48 81.43% | -0.37 25.88% | -0.48 7.81% | -0.04 88.41% | 1.53 416.90% |
| Revenue Q2Q % growth | 34.457M | 103.59M | |||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -8.633M 6.79% | -10.984M -37.49% | -13.29M -90.87% | 26.556M 456.97% | 128.33M 1,586.57% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
51.04%
EPS Next 5 Year
21.11%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
175.15%
EBIT Next 5 Year
N/A
UNICYCIVE THERAPEUTICS INC / UNCY Forecast FAQ
What is the next earnings date for UNCY stock?
UNICYCIVE THERAPEUTICS INC (UNCY) will report earnings on 2026-03-26, after the market close.
What are the consensus estimates for UNICYCIVE THERAPEUTICS INC (UNCY) next earnings?
The consensus EPS estimate for the next earnings of UNICYCIVE THERAPEUTICS INC (UNCY) is -0.48 USD and the consensus revenue estimate is 0 USD.
How many analysts cover UNICYCIVE THERAPEUTICS INC (UNCY) stock?
The number of analysts covering UNICYCIVE THERAPEUTICS INC (UNCY) is 14.